- Feb 1, 2018

Diabetes, Obesity & Hypertension 2018

The 6th World Congress on Controversies to Consensus in Diabetes,

Obesity and Hypertension (CODHy) to be held in Tel Aviv, Israel,

February 21-22, 2018.

Come see our poster and talk to us about our upcoming submission of our IND for Treating Type 2 Diabetes. Looking forward to seeing you there.

TREATING AND PREVENTING TYPE 2 DIABETES

Download • 147KB

READ MORE

Hi, thanks for stopping by!

Concenter BioPharma is a subsidiary of Silkim Pharma Ltd., which developed a novel, protected PLATFORM of drugs for proven treatments of multiple indications.

Our PLATFORM is the result of extensive investigation of animal models of human diseases.

Concenter

BioPharma

Diabetes, Obesity & Hypertension 2018

The 6th World Congress on Controversies to Consensus in Diabetes,

Obesity and Hypertension (CODHy) to be held in Tel Aviv, Israel,

February 21-22, 2018.

Come see our poster and talk to us about our upcoming submission of our IND for Treating Type 2 Diabetes. Looking forward to seeing you there.

Recent Posts

Hi, thanks for stopping by!

Let the news
come to you.

CONTACT US

Concenter

BioPharma

Diabetes, Obesity & Hypertension 2018

The 6th World Congress on Controversies to Consensus in Diabetes,

Obesity and Hypertension (CODHy) to be held in Tel Aviv, Israel,

February 21-22, 2018.

Come see our poster and talk to us about our upcoming submission of our IND for Treating Type 2 Diabetes. Looking forward to seeing you there.

Recent Posts

Hi, thanks for stopping by!

Let the news come to you.

Let the news
come to you.